Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

174 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low-Dose Ionizing γ-Radiation Elicits the Extrusion of Neutrophil Extracellular Traps.
Teijeira A, Garasa S, Ochoa MC, Sanchez-Gregorio S, Gomis G, Luri-Rey C, Martinez-Monge R, Pinci B, Valencia K, Palencia B, Barbés B, Bolaños E, Azpilikueta A, García-Cardosa M, Burguete J, Eguren-Santamaría I, Garate-Soraluze E, Berraondo P, Perez-Gracia JL, de Andrea CE, Rodriguez-Ruiz ME, Melero I. Teijeira A, et al. Among authors: perez gracia jl. Clin Cancer Res. 2024 Sep 13;30(18):4131-4142. doi: 10.1158/1078-0432.CCR-23-3860. Clin Cancer Res. 2024. PMID: 38630754 Free PMC article.
CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects.
Glez-Vaz J, Azpilikueta A, Ochoa MC, Olivera I, Gomis G, Cirella A, Luri-Rey C, Álvarez M, Pérez-Gracia JL, Ciordia S, Eguren-Santamaria I, Alexandru R, Berraondo P, de Andrea C, Teijeira Á, Corrales F, Zapata JM, Melero I. Glez-Vaz J, et al. Sci Adv. 2023 Aug 18;9(33):eadf6692. doi: 10.1126/sciadv.adf6692. Epub 2023 Aug 18. Sci Adv. 2023. PMID: 37595047 Free PMC article.
PSA reactivity in extracellular microvesicles to commercial immunoassays.
Sandúa A, Sanmamed MF, Rodríguez M, Ancizu-Marckert J, Gúrpide A, Perez-Gracia JL, Alegre E, González Á. Sandúa A, et al. Clin Chim Acta. 2023 Mar 15;543:117303. doi: 10.1016/j.cca.2023.117303. Epub 2023 Mar 21. Clin Chim Acta. 2023. PMID: 36948237 Free article.
Dendritic Cells in Cancer Immunology and Immunotherapy.
Hato L, Vizcay A, Eguren I, Pérez-Gracia JL, Rodríguez J, Gállego Pérez-Larraya J, Sarobe P, Inogés S, Díaz de Cerio AL, Santisteban M. Hato L, et al. Among authors: perez gracia jl. Cancers (Basel). 2024 Feb 28;16(5):981. doi: 10.3390/cancers16050981. Cancers (Basel). 2024. PMID: 38473341 Free PMC article. Review.
Comparison of staging using [68Ga]Ga-PSMA-11 PET/CT and histopathological results in intermediate- and high-risk prostate cancer patients treated with radical prostatectomy and pelvic lymph node dissection.
Rosales JJ, Betech Antar V, Mínguez F, Pareja F, Guillén F, Prieto E, Quincoces G, Caballero FD, Miñana B, Pérez-Gracia JL, Rodríguez-Fraile M. Rosales JJ, et al. Among authors: perez gracia jl. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2024 Oct 28:500076. doi: 10.1016/j.remnie.2024.500076. Online ahead of print. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2024. PMID: 39477086
Targeting T-cell costimulation to the surface of tumor cells.
Eguren-Santamaría I, Sanmamed MF, Molero-Glez P, Perez-Gracia JL, Melero I. Eguren-Santamaría I, et al. Among authors: perez gracia jl. Clin Cancer Res. 2024 Nov 12. doi: 10.1158/1078-0432.CCR-24-3003. Online ahead of print. Clin Cancer Res. 2024. PMID: 39531541
Retrospective study assessing the role of the androgen receptor in clear cell renal cell cancer patients treated with VEGFR inhibitors in monotherapy.
Osorio L, Grazioso TP, de Velasco G, Etxaniz O, Pérez-Gracia JL, Pinto Á, Durán I, Grande E, Garcia PB, Lázaro M, Rodriguez L, Villalobos ML, García L, Cuellar A, Solís-Hernández MP, Pernaut C, Rodríguez-Moreno JF, Rodriguez-Antona C, García-Donas J. Osorio L, et al. Among authors: perez gracia jl. Clin Transl Oncol. 2024 Oct 4. doi: 10.1007/s12094-024-03652-9. Online ahead of print. Clin Transl Oncol. 2024. PMID: 39365364
Induction avelumab followed by chemoimmunotherapy and maintenance versus chemotherapy alone as first-line therapy in cis-ineligible metastatic urothelial carcinoma (INDUCOMAIN): a randomized phase II study.
Rodriguez-Vida A, Valderrama BP, Castellano D, Pinto A, Mellado B, Puente J, Climent MA, Domenech M, Vazquez F, Perez-Gracia JL, Bonfill T, Morales-Barrera R, Gonzalez-Billalabeitia E, Garcia-Del-Muro X, Maroto P, Navarro-Gorro N, Juanpere N, Juan O, Bellmunt J. Rodriguez-Vida A, et al. Among authors: perez gracia jl. ESMO Open. 2024 Sep;9(9):103690. doi: 10.1016/j.esmoop.2024.103690. Epub 2024 Aug 29. ESMO Open. 2024. PMID: 39214051 Free PMC article. Clinical Trial.
PARP inhibitors alone or in combination for prostate cancer.
Fenor de la Maza MD, Pérez Gracia JL, Miñana B, Castro E. Fenor de la Maza MD, et al. Among authors: perez gracia jl. Ther Adv Urol. 2024 Aug 24;16:17562872241272929. doi: 10.1177/17562872241272929. eCollection 2024 Jan-Dec. Ther Adv Urol. 2024. PMID: 39184454 Free PMC article. Review.
174 results